Evidence map›Paper›PMID 36160140›Full record

ArticleFrontiers in medicine2022

Functional consequence of myeloid ferritin heavy chain on acute and chronic effects of rhabdomyolysis-induced kidney injury.

Kayla R McCullough, Juheb Akhter, Mauhaun J Taheri, Amie Traylor, Anna A Zmijewska, Vivek Verma, Matthew C Hudson, Abhishek Sachdeva, Elise N Erman, Kyle H Moore and 2 more

Abstract read
In one paragraph

Article in Frontiers in medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Kayla R McCulloughDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States.
Juheb AkhterDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States.
Mauhaun J TaheriDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States.
Amie TraylorDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States.
Anna A ZmijewskaDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States.
Vivek VermaDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States.
Matthew C HudsonDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States.
Abhishek SachdevaDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States.
Elise N ErmanDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States.
Kyle H MooreDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States.
James F GeorgeDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States.
Subhashini BolisettyDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States.

Funding

Functional Significance of Ferritin Light Chain in Sepsis-associated Kidney InjuryR01DK122986 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BOLISETTY, SUBHASHINI · 2021 to 2025
$1.7M
NIDDK NIH HHS R01 DK122986
6 · The paper itself

Abstract

Acute kidney injury (AKI) is a serious complication of rhabdomyolysis that significantly impacts survival. Myoglobin released from the damaged muscle accumulates in the kidney, causing heme iron-mediated oxidative stress, tubular cell death, and inflammation. In response to injury, myeloid cells, specifically neutrophils and macrophages, infiltrate the kidneys, and mediate response to injury. Ferritin, comprised of ferritin light chain and ferritin heavy chain (FtH), is vital for intracellular iron handling. Given the dominant role of macrophages and heme-iron burden in the pathogenesis of rhabdomyolysis, we studied the functional role of myeloid FtH in rhabdomyolysis-induced AKI and subsequent fibrosis. Using two models of rhabdomyolysis induced AKI, we found that during the acute phase, myeloid FtH deletion did not impact rhabdomyolysis-induced kidney injury, cell death or cell proliferation, suggesting that tubular heme burden is the dominant injury mechanism. We also determined that, while the kidney architecture was markedly improved after 28 days, tubular casts persisted in the kidneys, suggesting sustained damage or incomplete recovery. We further showed that rhabdomyolysis resulted in an abundance of disparate intra-renal immune cell populations, such that myeloid populations dominated during the acute phase and lymphoid populations dominated in the chronic phase. Fibrotic remodeling was induced in both genotypes at 7 days post-injury but continued to progress only in wild-type mice. This was accompanied by an increase in expression of pro-fibrogenic and immunomodulatory proteins, such as transforming growth factor-β, S100A8, and tumor necrosis factor-α. Taken together, we found that while the initial injury response to heme burden was similar, myeloid FtH deficiency was associated with lesser interstitial fibrosis. Future studies are warranted to determine whether this differential fibrotic remodeling will render these animals more susceptible to a second AKI insult or progress to chronic kidney disease at an accelerated pace.

Indexed as

ferritinferritin heavy chainfibrosisinflammatory responseironkidneymacrophagesrhabdomyolysis

Identifiers

PMID36160140
PMCPMC9492979

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.